Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes.
AML
DNA accessibility
acute myeloid leukemia
chromatin states
epigenome
histone marks
stemness
transcriptome
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
22 01 2019
22 01 2019
Historique:
received:
27
06
2018
revised:
27
09
2018
accepted:
21
12
2018
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
7
3
2020
Statut:
ppublish
Résumé
Global investigation of histone marks in acute myeloid leukemia (AML) remains limited. Analyses of 38 AML samples through integrated transcriptional and chromatin mark analysis exposes 2 major subtypes. One subtype is dominated by patients with NPM1 mutations or MLL-fusion genes, shows activation of the regulatory pathways involving HOX-family genes as targets, and displays high self-renewal capacity and stemness. The second subtype is enriched for RUNX1 or spliceosome mutations, suggesting potential interplay between the 2 aberrations, and mainly depends on IRF family regulators. Cellular consequences in prognosis predict a relatively worse outcome for the first subtype. Our integrated profiling establishes a rich resource to probe AML subtypes on the basis of expression and chromatin data.
Identifiants
pubmed: 30673601
pii: S2211-1247(18)32058-8
doi: 10.1016/j.celrep.2018.12.098
pmc: PMC6363099
mid: EMS81493
pii:
doi:
Substances chimiques
Chromatin
0
Core Binding Factor Alpha 2 Subunit
0
NPM1 protein, human
0
Nuclear Proteins
0
Oncogene Proteins, Fusion
0
RUNX1 protein, human
0
Nucleophosmin
117896-08-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1059-1069.e6Subventions
Organisme : Wellcome Trust
ID : 108749
Pays : United Kingdom
Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.